Search

Your search keyword '"Testa, Laura"' showing total 199 results

Search Constraints

Start Over You searched for: Author "Testa, Laura" Remove constraint Author: "Testa, Laura"
199 results on '"Testa, Laura"'

Search Results

51. Contribution of tumour and immune cells to PD-L1 as a predictive biomarker in metastatic triple-negative breast cancer (mTNBC): analysis from keynote-119

52. Abemaciclib combined with adjuvant endocrine therapy in patients with high risk early breast cancer who received neoadjuvant chemotherapy (NAC).

53. Adjuvant Treatment with 5-Fluorouracil and Oxaliplatin Does Not Influence Cardiac Function, Neurovascular Control, and Physical Capacity in Patients with Colon Cancer

54. Câncer e Doenças Cardiovasculares na Pandemia de COVID-19

55. Abstract GS1-01: Primary outcome analysis of invasive disease-free survival for monarchE: abemaciclib combined with adjuvant endocrine therapy for high risk early breast cancer

56. Abstract PS12-01: Pembrolizumab versus chemotherapy for previously treated metastatic triple-negative breast cancer (KEYNOTE-119): Efficacy in patients with lung or liver metastases

59. Abstract PD14-04: Contribution of tumor and immune cells to PD-L1 as a predictive biomarker in triple-negative breast cancer (TNBC): Analysis from KEYNOTE-119

60. Phase II trial of humanized anti-Lewis Y monoclonal antibody for advanced hormone receptor-positive breast cancer that progressed following endocrine therapy

61. Phase II Trial of Humanized Anti-Lewis Y Monoclonal Antibody for Advanced Hormone Receptor-positive Breast Cancer That Progressed on Previous Endocrine Therapy

62. Diretriz Brasileira de Cardio-oncologia – 2020

63. Câncer e Doenças Cardiovasculares na Pandemia de COVID-19

64. Adjuvant Treatment with 5-Fluorouracil and Oxaliplatin Does Not Influence Cardiac Function, Neurovascular Control, and Physical Capacity in Patients with Colon Cancer

66. Association of tumor mutational burden (TMB) and clinical outcomes with pembrolizumab (pembro) versus chemotherapy (chemo) in patients with metastatic triple-negative breast cancer (mTNBC) from KEYNOTE-119.

68. Abstract PD5-03: Relationship between tumor-infiltrating lymphocytes (TILs) and outcomes in the KEYNOTE-119 study of pembrolizumab vs chemotherapy for previously treated metastatic triple-negative breast cancer (mTNBC)

71. Chemotherapy acutely impairs neurovascular and hemodynamic responses in women with breast cancer

72. Chemotherapy acutely impairs neurovascular and hemodynamic responses in patients with breast cancer

73. REAL-LIFE EXPERIENCE OF TRASTUZUMAB USE AMONG 806 BREAST CANCER PATIENTS: ROLE OF ROUTINE SERIAL ECHOCARDIOGRAPHY FOR THE EVALUATION OF ASYMPTOMATIC VENTRICULAR DYSFUNCTION IN THE FIRST 6 MONTHS OF TRASTUZUMAB THERAPY

74. Cancer During Pregnancy: The Oncologist Overview

77. Do socioeconomic status and comorbidity affect survival in women with breast cancer living in the city of São Paulo, Brazil?

82. Biodiversity, evolution and adaptation of fungi in extreme environments

84. Biodiversity, evolution and adaptation of fungi in extreme environments

85. Feasibility of two schedules of weekly paclitaxel as (neo)adjuvant treatment for patients (PTS) with HER2-negative breast cancer (BC) in the Brazilian community setting.

86. Driven Cowgirl Blues.

87. Reading about Sex.

88. Go away "Go Fish".

90. A Gay Evening in May.

91. All in a Moment.

92. Santa Cruz Celebration of Pride.

93. CyberSex.

94. A Book for Travel.

95. Honey of an Album.

96. Where is Our Herstory?

97. Julie Gates: Good Earth Landscaping.

98. Other Lives Other Videos.

99. PERFORMANCE ART.

100. Activity of capecitabine for central nervous system metastases from breast cancer.

Catalog

Books, media, physical & digital resources